Managed-service-based platform allows manufacturers to automate GRC communications with third parties
For pharma companies operating under Corporate Integrity Agreements (CIAs) or self-imposed GRC programs for anti-bribery rules, HIPAA compliance or contracts involving fair market value (FMV) assessments, documenting the compliance of third parties can be a headache. With outsourced vendor agreements numbering in the hundreds or more, each vendor’s internal processes need to be documented and reported. Avior Computing (Nashua, NH) has developed a software platform, called BenchMark, to automate this process; now the company is offering it as an outsourced service to manufacturers, healthcare providers and others.
Using a portal that Avior sets up, a company can build a database of suppliers or other partners and run the program according to its own specifications. Avior provides a library of predesigned rules libraries, addressing such industry requirements as the Foreign Corrupt Practices Act, HIPAA, ICD-10 (the schema for reporting billable medical interventions) and other rules. Libraries include medical affairs, marketing compliance, pharmacovigilance and others. “Instead of a company sending out assessments manually to third parties hand-picked as offering the highest risk, staff can send them out to all their third parties at once,” says Todd Martin, Avior’s director of life sciences. The service flags noncompliant items, reducing the administrative burden because staff has to deal only with a relatively small number of exceptions. The service allows staff to create a remediation for a third party to address by a selected date.
Companies also can create their own assessments. For example, with training from Avior, a company can create questions for assessment of employees’ compliance with its standard operating procedures (SOPs), with Avior mapping the questions to items in the control; ie, the SOP. The service will flag noncompliant responses, allowing appropriate staff to address the issues. The managed-services arrangement requires a month-to-month subscription based on the number of entities being monitored; for example, 50 third parties for $4,000 per month.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.